Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06072625

Enteral Feeding of Premature Babies and Olive Oil Supplementation

The Effect of Enteral Organic Extra Virgin Olive Oil Supplementation in Premature Babies on Postnatal Growth and Premature Morbidities

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Bursa City Hospital · Other Government
Sex
All
Age
14 Days – 40 Days
Healthy volunteers
Accepted

Summary

It is a two-arm prospective interventional study. 40 babies in both groups will be enrolment in the study. In the intervention group, babies will take 1 ml/kg/day of the study product (ULTRA PREMIUM) after full enteral feeding. Supplementation will continue until discharge or the 36th week. Blood samples will be taken for serum Total antioxidant capacity and Malondialdehyde levels before the intervention and on the 14th day of the control group. At the end of the study, serum will be taken again for control values. Daily lipid intake amounts will be recorded through breast milk analysis. Lipid profile will be monitored weekly The growth parameters of babies will be monitored daily It will be evaluated at the end of the study in terms of ROP, BPD, and NEC. At the end of the study, the data of babies in both groups will be compared.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTExtra virgin organic olive oil (ULTRA PREMIUM)Babies who have fully enteral feeding will take oral, 1 ml/kg/day of extra virgin olive-oil

Timeline

Start date
2023-10-01
Primary completion
2024-12-31
Completion
2025-03-31
First posted
2023-10-10
Last updated
2024-07-15

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06072625. Inclusion in this directory is not an endorsement.